Deutsche Bank lowered the firm’s price target on Eli Lilly (LLY) to $900 from $1,010 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- VOO ETF News, 8/11/2025
- Eli Lilly’s Stock Dips Amid Weight-Loss Pill Setback
- IonQ, Eli Lilly, Monster, Crocs, Kratos Trending by Analysts
- Sector Spotlight: Trump administration seeks hometown discount from Big Pharma
- Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!